IL-10 and the JAK-STAT Pathway in the Regulation of Metabolism and Mucosal Homeostasis
PhD Dissertation - Yu Hui Kang Final v2.docx (18.44Mb)
Access StatusFull text of the requested work is not available in DASH at this time ("dark deposit"). For more information on dark deposits, see our FAQ.
Kang, Yu Hui
MetadataShow full item record
CitationKang, Yu Hui. 2019. IL-10 and the JAK-STAT Pathway in the Regulation of Metabolism and Mucosal Homeostasis. Doctoral dissertation, Harvard University, Graduate School of Arts & Sciences.
AbstractThe JAK-STAT pathway integrates signals from multiple cytokines to elicit a specific output, and aberrations in this pathway contribute to the pathogenesis of multiple diseases such as inflammatory bowel disease (IBD). Interleukin 10 (IL-10), for example, utilizes STAT3 to suppress inflammation, and mutations in IL-10 or its receptor have been associated with IBD. However, it is currently unclear how the JAK-STAT pathway achieves specificity and how it contributes to IBD. Here, we investigate the roles of STAT1 in IBD and STAT3 in IL-10R signaling.
We first investigated how CD4+ T cells use STAT1 to drive intestinal inflammation. In an adoptive transfer model, Stat1-/- T cells are unable to expand and induce colitis. This defect is only partially explained by the loss of Type I and II interferon signaling. Mechanistically, Stat1-/- T cells display reduced expression of Nlrc5 and multiple MHC class I molecules, which are inhibitors of NK cell killing. Consequently, NK cell depletion significantly rescues the survival of Stat1-/- T cells and restores colitis induction. Interestingly, only Stat1-/- T cells that underwent spontaneous proliferation are eliminated, suggesting that NK cells specifically target microbially activated T cells. Stat1-/- mice have normal CD4+ T cell numbers as innate STAT1 signaling is required for their elimination. Together, our data points to a critical role for STAT1 in shielding T cells from NK cell mediated cytotoxicity.
Next, we investigated how IL-10 utilizes STAT3 to achieve specificity, hypothesizing that IL-10-STAT3 might exhibit non-canonical functions outside of the nucleus. We show that, in addition to the nucleus, IL-10 also induces activated pSTAT3 in macrophage mitochondria. Upon acute IL-10 stimulation, STAT3 interacted with multiple mitochondrial proteins. This correlated with metabolic changes that indicate enhanced functions of these proteins. STAT3’s DNA binding activity is not required for IL-10 to inhibit pro-inflammatory gene expression, suggesting that non-transcriptional functions of STAT3 are sufficient for IL-10 mediated suppression. However, IL-10 requires STAT3 mediated transcription to enhance anti-inflammatory M2 macrophage polarization, suggesting that IL-10-dependent non-canonical STAT3 acts specifically to regulate the metabolic state during inflammation. Together, our data reveals a novel mechanism of IL-10R-STAT3 signaling that might explain its immunosuppressive effects.
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:42013036
- FAS Theses and Dissertations